ZOLL to Host First Dubai Cardiac Arrest Symposium
|
By HospiMedica International staff writers Posted on 11 Feb 2014 |
|
ZOLL Medical Corporation (Chelmsford, MA, USA), a leading manufacturer of medical devices and related software solutions, will host the first Dubai Cardiac Arrest Symposium together with the Emirates Cardiac Society (Abu Dhabi, UAE).
The symposium, which will take place on February 22, 2014, at the Crowne Plaza Dubai (UAE), will focus on addressing ways to improve outcomes in resuscitation in the Gulf and Arab states, and is expected to attract an audience of cardiologists, emergency physicians, anesthesiologists, and resuscitation officers and directors from throughout the Middle East. The opening speaker is the chairman of the event, Alawi Alsheikh-Ali, MD, President of ECS, who will present “Cardiac arrest in the Gulf—Where are the data?”
In addition, leading experts in cardiology from around the world will address related topics such as cardiopulmonary resuscitation (CPR) awareness; high-quality CPR in relationship to success; pre-hospital cardiac arrest management from pavement to percutaneous coronary intervention (PCI); and ZOLL AutoPulse-facilitated PCI for out-of-hospital cardiac arrest. A sudden cardiac arrest survivor will conclude the symposium with a presentation entitled “I shouldn’t be alive.”
“Sudden cardiac arrest is the leading cause of unexpected death around the world, killing as many as one million people annually,” said Jonathan A. Rennert, president of ZOLL. “Yet many of these deaths are potentially preventable when high-quality CPR is delivered. Advancing resuscitation care could improve survival from this major worldwide health problem.”
The Emirates Cardiac Society is a network of all cardiologists in the UAE that works under the umbrella of the Emirates Medical Association (EMA; Dubai, UAE). Its mission is to educate public and healthcare professionals in reducing the burden of cardiovascular disease in the UAE. The ECS promotes health education within the community, raises awareness of health issues among the general population, and establishes strong partnerships with national and international health agencies and establishments.
Related Links:
ZOLL Medical Corporation
Emirates Cardiac Society
Emirates Medical Association
The symposium, which will take place on February 22, 2014, at the Crowne Plaza Dubai (UAE), will focus on addressing ways to improve outcomes in resuscitation in the Gulf and Arab states, and is expected to attract an audience of cardiologists, emergency physicians, anesthesiologists, and resuscitation officers and directors from throughout the Middle East. The opening speaker is the chairman of the event, Alawi Alsheikh-Ali, MD, President of ECS, who will present “Cardiac arrest in the Gulf—Where are the data?”
In addition, leading experts in cardiology from around the world will address related topics such as cardiopulmonary resuscitation (CPR) awareness; high-quality CPR in relationship to success; pre-hospital cardiac arrest management from pavement to percutaneous coronary intervention (PCI); and ZOLL AutoPulse-facilitated PCI for out-of-hospital cardiac arrest. A sudden cardiac arrest survivor will conclude the symposium with a presentation entitled “I shouldn’t be alive.”
“Sudden cardiac arrest is the leading cause of unexpected death around the world, killing as many as one million people annually,” said Jonathan A. Rennert, president of ZOLL. “Yet many of these deaths are potentially preventable when high-quality CPR is delivered. Advancing resuscitation care could improve survival from this major worldwide health problem.”
The Emirates Cardiac Society is a network of all cardiologists in the UAE that works under the umbrella of the Emirates Medical Association (EMA; Dubai, UAE). Its mission is to educate public and healthcare professionals in reducing the burden of cardiovascular disease in the UAE. The ECS promotes health education within the community, raises awareness of health issues among the general population, and establishes strong partnerships with national and international health agencies and establishments.
Related Links:
ZOLL Medical Corporation
Emirates Cardiac Society
Emirates Medical Association
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Endoscopy Display
E190
Emergency Ventilator
Shangrila935
Latest Business News
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- Boston Scientific Acquires Medical Device Company SoniVie
- 2026 World Hospital Congress to be Held in Seoul
- Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
Channels
Artificial Intelligence
view channel
Surgical Techniques
view channel
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read more
New Imaging Combo Offers Hope for High-Risk Heart Patients
Patients with type 2 diabetes often develop complex, severe coronary artery disease involving multiple narrowed or blocked arteries, making complete revascularization difficult. Without detailed functional... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more